Updated Sepsis Bundle: Key Components
The updated sepsis bundle emphasizes immediate recognition and treatment within the first hour, with core interventions including: obtaining blood cultures, administering broad-spectrum antibiotics within 1 hour, delivering 30 mL/kg crystalloid fluid resuscitation within 3 hours, measuring lactate, and applying vasopressors for persistent hypotension targeting MAP ≥65 mmHg. 1, 2, 3
Critical Shift from 2012 to 2016 Guidelines
The most significant evolution in sepsis management is the recognition that sepsis and septic shock are medical emergencies requiring immediate treatment rather than protocolized 6-hour resuscitation. 4
What Changed:
2012 approach focused on specific hemodynamic targets within 6 hours including central venous pressure (8-12 mmHg), central venous oxygen saturation (70%), and urine output (≥0.5 mL/kg/hr). 4
2016 updated approach eliminated rigid CVP and ScvO2 targets in favor of clinical reassessment and dynamic variables, emphasizing speed of intervention over specific numerical endpoints. 4
The Hour-1 Bundle Components
1. Lactate Measurement
- Measure serum lactate immediately upon sepsis recognition 1, 2, 3
- Remeasure lactate within 6 hours if initially elevated, targeting clearance of at least 10% every 2 hours during the first 8 hours 2, 3
- Elevated lactate (>4 mmol/L) serves as an objective marker of tissue hypoperfusion and predicts worse outcomes 2
2. Blood Cultures Before Antibiotics
- Obtain at least 2 sets of blood cultures (aerobic and anaerobic) before antimicrobial therapy 1, 2, 3
- Draw at least one percutaneously and one through each vascular access device unless recently inserted (<48 hours) 4
- Critical caveat: Never delay antibiotic administration beyond 1 hour to obtain cultures 1, 3
3. Broad-Spectrum Antimicrobials Within 1 Hour
- Administer effective IV antimicrobials within the first hour of sepsis recognition—this is the single most critical intervention 1
- Each hour of delay in antibiotic administration increases risk-adjusted mortality (odds ratio 1.04 per hour, 95% CI 1.03-1.06) 5
- Initial empiric therapy must include drugs active against all likely pathogens (bacterial, fungal, or viral) 1
Antimicrobial selection strategy:
- Use broad-spectrum beta-lactam for community-acquired sepsis 1
- Add vancomycin or linezolid for suspected MRSA 1
- For suspected Pseudomonas, use extended-spectrum beta-lactam plus aminoglycoside or fluoroquinolone 1
- For neutropenic patients, use combination empirical therapy 1
4. Aggressive Fluid Resuscitation
- Deliver at least 30 mL/kg IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion 4, 1
- Continue fluid challenges as long as hemodynamic parameters improve based on frequent clinical reassessment 4
- Use crystalloids (preferably balanced solutions) over colloids; avoid hydroxyethyl starches entirely 2, 3
Reassessment parameters include:
- Heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, urine output, and mental status 4
- Dynamic variables (pulse pressure variation, stroke volume variation) are preferred over static variables (CVP) when available 4
5. Vasopressor Support
- Initiate vasopressors if hypotension persists after initial fluid resuscitation 1, 2, 3
- Target mean arterial pressure (MAP) ≥65 mmHg 4, 1
- Norepinephrine is the first-choice vasopressor 1, 3
- Consider adding vasopressin if hypotension persists despite norepinephrine 1
Additional Management Bundle Elements (Within 24 Hours)
Glucose Control
- Maintain blood glucose above lower limit of normal but <150 mg/dL (8.3 mmol/L) 2, 3
- Commence insulin when two consecutive levels exceed 180 mg/dL 2, 3
- Tight glucose control showed risk-adjusted odds ratio for mortality of 0.67 (95% CI 0.62-0.71) 2
Mechanical Ventilation Strategy
- Use low tidal volume ventilation for mechanically ventilated patients 2, 3
- Maintain inspiratory plateau pressures <30 cm H₂O 2, 3
- Place patients in semi-recumbent position (head of bed 30-45°) 4
Corticosteroids
- Administer low-dose steroids (hydrocortisone up to 300 mg/day or prednisolone up to 75 mg/day) for septic shock requiring escalating vasopressor doses 4, 2, 3
Antimicrobial Optimization and De-escalation
- Reassess antimicrobial regimen daily for potential de-escalation 1
- Empiric combination therapy should not continue beyond 3-5 days 1
- De-escalate to most appropriate single therapy once susceptibility profile is known 1
- Typical duration of therapy is 7-10 days 1
Screening and Performance Improvement
- Hospitals must have performance improvement programs for sepsis, including routine screening of acutely ill, high-risk patients 4
- Complete bundle compliance reduces mortality with a number needed to treat of 15 patients to save one life 2
Critical Pitfalls to Avoid
Timing Errors
- Never delay antibiotics beyond 1 hour for any reason, including obtaining cultures or diagnostic imaging 1, 3
- Do not wait for lactate results before initiating treatment 2
Fluid Management Errors
- Avoid aggressive fluid resuscitation in patients with documented ventricular dysfunction 2
- Do not use hydroxyethyl starches for volume replacement 2
- Avoid albumin in traumatic brain injury 6
Vasopressor Errors
Antimicrobial Errors
- Avoid inadequate dosing that doesn't account for altered pharmacokinetics in sepsis 1
- Do not continue broad-spectrum antibiotics unnecessarily once pathogen is identified 1
Source Control
- Control the anatomic source of infection as soon as possible through drainage, debridement, or device removal 4
- Surgical source control timing must balance urgency with patient optimization 4
- Consider damage control surgery for severe intra-abdominal sepsis with physiologic derangement 4